Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
RefMet: Metabolite Nomenclature
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Clustering data with hclust algorithm for (Study ST002475)
(Analysis AN004042)
Metabolite
Structure
F1
F2
F3
Phenylacetyl-l-glutamine
ME585071
0.28
2.48
0.55
1-(1z-hexadecenyl)-sn-glycero-3-phosphocholine
ME585126
0.44
2.33
0.47
Sipeimine
ME585107
0.50
2.25
0.47
L-pyroglutamic acid
ME585128
0.09
3.19
0.12
Metformin
ME585104
0.01
3.34
0.09
Coclaurine
ME585127
0.24
2.77
0.33
L-pipecolic acid
ME585130
0.25
2.95
0.13
Clorgyline
ME585078
1.91
0.36
0.42
Lappaconitine
ME585084
1.45
0.50
0.88
4-cholestenone
ME585074
1.59
0.46
0.74
Asp-Arg
ME585101
1.53
0.52
0.75
3-ethylphenol
ME585122
1.71
0.58
0.46
1,5-naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl]-
ME585073
1.61
0.62
0.55
1-octadecyl lysophosphatidic acid
ME585124
1.55
0.66
0.59
Harmane
ME585110
1.56
0.70
0.55
Cys-Trp-Arg
ME585081
1.33
0.49
1.05
Steviol
ME585109
1.22
0.62
1.08
Fenpropidin
ME585063
1.31
0.91
0.67
4-nitrosodiphenylamine
ME585115
1.42
0.75
0.69
Hypoxanthine
ME585080
1.37
0.78
0.72
Palmitoyl 3-carbacyclic phosphatidic acid
ME585072
1.38
0.61
0.86
Benzamide
ME585092
1.37
0.69
0.81
18.beta.-glycyrrhetinic acid
ME585129
1.44
0.64
0.76
Guaiacol methyl ether
ME585079
1.40
0.69
0.77
Palmitoleoyl 3-carbacyclic phosphatidic acid
ME585113
1.42
0.67
0.76
L-Arginine
ME585112
1.13
0.77
1.04
4.alpha.-hydroxystanozolol
ME585087
1.30
0.67
0.91
(4r)-4-((5s,7r,9s,10s,13r,14s,17r)-7-hydroxy-10,13-dimethyl-3-oxohexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid
ME585106
1.31
0.60
0.97
12-ketodeoxycholic acid
ME585118
1.22
0.74
0.95
Carbofuran phenol-3-ketone
ME585077
1.24
0.73
0.95
8,11-tridecadienoic acid, 13-(3-pentyl-2-oxiranyl)-, methyl ester, (8z,11z)-
ME585111
1.28
0.76
0.86
C17-sphinganine
ME585050
1.22
0.84
0.86
Nicotinate
ME585083
1.25
0.80
0.86
Cyclohexylamine
ME585089
1.34
0.26
1.25
Tributyrin
ME585064
1.20
0.33
1.38
Urobilin
ME585123
1.20
0.38
1.32
2-mohpda [dmed-fahfa]
ME585121
1.70
0.19
0.85
1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine
ME585086
1.51
0.24
1.05
2-mohma [dmed-fahfa]
ME585093
1.50
0.23
1.06
Lavandulol
ME585120
0.22
0.88
2.14
Trigonelline
ME585076
0.76
1.82
0.54
Oleoyl-l-carnitine
ME585102
0.51
1.84
0.85
1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine
ME585090
0.52
1.93
0.74
Betaine
ME585052
0.61
1.85
0.71
S-methyl-5^-thioadenosine
ME585097
0.41
1.71
1.11
Glu-His
ME585131
0.49
1.77
0.95
Cytidine
ME585105
0.51
1.69
0.99
N-acetylsphingosine
ME585069
0.51
1.71
0.97
Indole
ME585119
0.27
1.95
1.06
2-[[7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
ME585091
0.34
2.04
0.88
Decahydrogambogic acid
ME585114
0.35
2.17
0.75
N-acetyl-d-lactosamine
ME585125
0.25
2.21
0.84
2-(2-butoxyethoxy)acetic acid
ME585070
0.45
1.41
1.33
2-dimethylamino-6-hydroxypurine
ME585065
0.46
1.34
1.39
17-trifluoromethylphenyltrinorprostaglandin f2.alpha. methyl ester
ME585058
0.50
1.43
1.26
Hc toxin
ME585059
0.50
1.45
1.22
Ethyl 3-hydroxybutyrate
ME585053
0.52
1.43
1.22
17-trifluoromethylphenyltrinorprostaglandin f2.alpha. isopropyl ester
ME585060
0.54
1.42
1.21
Tetraethylene glycol
ME585054
0.53
1.43
1.21
2,3-dinor-8-isoprostaglandin-f2.alpha.
ME585066
0.60
1.33
1.21
Biliverdin
ME585116
0.61
1.35
1.18
Isobutyric acid
ME585056
0.59
1.36
1.20
L-palmitoylcarnitine
ME585100
0.54
1.38
1.24
2-piperidinecarboxylic acid, 1-(3,3-dimethyl-1,2-dioxopentyl)-, (1r)-1-(3-aminophenyl)-3-(3,4-dimethoxyphenyl)propyl ester, (2s)-
ME585068
0.56
1.33
1.27
Octaethylene glycol
ME585062
0.53
1.35
1.28
Beta-octylglucoside
ME585103
0.48
1.57
1.14
Linoleoylcarnitine
ME585098
0.52
1.58
1.08
Linoleoyl ethanolamide
ME585085
0.56
1.52
1.08
Dibucaine
ME585057
0.44
1.49
1.27
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1h-indole-3-carboxamide
ME585055
0.43
1.49
1.29
Creatinine
ME585096
0.40
1.60
1.22
Myristoyl-l-carnitine
ME585075
0.42
1.57
1.23
7,8-didehydroastaxanthin
ME585094
0.68
1.34
1.10
Glycerophosphocholine
ME585082
0.75
1.37
0.99
Pyridoxal
ME585099
0.76
1.50
0.83
Mifepristone
ME585061
0.67
1.52
0.94
.alpha.-linolenoyl ethanolamide
ME585067
0.63
1.58
0.94
Betaine aldehyde
ME585108
0.62
1.63
0.90
2-aminobenzamide
ME585088
0.50
1.01
1.64
Methyl (1-(cyclohexylmethyl)-1h-indole-3-carbonyl)-l-valinate
ME585051
0.19
1.60
1.50
Arcaine
ME585095
0.35
1.33
1.54
Daidzein
ME585117
0.26
1.29
1.69
Factors:
F1
treatment:Control
F2
treatment:Placebo
F3
treatment:Treatment
Data matrix
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel